Category:
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
TherageniX and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration
Dr Anandkumar Nandakumar, CEO of TherageniX, commented: “Our mission is to advance treatments in repairing tissue damage and we are grateful for the support from Innovate UK at this early stage. This grant is a testament to the potential of TherageniX’s novel approach to tissue regeneration and will enable us to make great strides in manufacturing our powdered gene therapy.
Radiaction Medical Raises $12.6 Million in Series C2 Funding
Jonathan Yifat, Radiaction Medical CEO, is enthusiastic about this next phase, saying, “This current financing round is a significant step forward, one that enables us to expand our reach further, lead with exceptional customer support, and provide this essential technology to protect those who care for patients.”
Delphinus Medical Technologies Raises $12 Million as Footprint Continues to Expand
Mark J. Forchette, president and CEO of Delphinus Medical Technologies. “SoftVue provides a comprehensive solution that enables providers to transform their patients’ clinical experience. Our relationship with Trinity Capital helps us make impactful investments in execution, to help our clinical partners embrace this innovation, and serve the unmet needs of patients with dense breast tissue that SoftVue was designed to address.”
Instylla Announces Completion of $30MM EQUITY Financing
As part of this round of financing, Henry Chen, Managing Partner, Delos Capital has joined the Instylla Board of Directors. "Instylla has demonstrated impressive progress, having already advanced its next-generation liquid embolic technology to human clinical studies. We are honored and thrilled to support Instylla as it continues developing breakthrough solutions that will meaningfully improve patient outcomes," said Henry Chen.
Persist AI Raises $4M in Seed Financing, Rapidly Accelerates Drug Formulation
Over the past 6 months, Persist AI has developed cutting- edge robotics that enables automated development of long-acting injectable formulations. Coupled with AI models, they are able to rapidly predict which formulations will release drugs in the body for a long time and reduce the number of injections that patients need.
Enspire DBS Therapy Announces $17.6 Million Series B Financing to Advance the Development of Deep Brain Stimulation (DBS) plus Rehabilitation for Stroke Patients
Enspire DBS Therapy plans to use the proceeds to initiate the RESTORE pivotal clinical trial using deep brain stimulation (DBS) and rehab therapy (DBS + Rehab) to treat patients with chronic upper extremity impairment due to stroke.
OrganOx, a Life-Saving Medical Device Company Transforming Organ Transplantation, Has Raised a £25m Growth Round led by Lauxera Capital Partners
Lauxera Capital Partners has led a £25m growth investment into OrganOx, a commercial-stage, Oxford, England-based medical device company. OrganOx develops and commercializes organ preservation...
Gleamer raises €27 Million in Series B Funding Round
This new investment will enable Gleamer to expand its portfolio of solutions, strengthen its European and American teams, and accelerate its international development plans. Total funds raised to date amount to €36 million (which includes a Series A funding round of €7.5 million in 2020 and seed funding of €1.5 million in 2018).
Presidio Medical Announces $72M Equity Fundraising Led by Deerfield
In conjunction with this financing David Neustaedter, Ph.D., Venture Partner, Deerfield Management Company, has joined the Presidio Medical Board of Directors.
Medical Device News Magazine
